Literature DB >> 20530791

Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Markus Moll1, Sofia K Andersson, Anna Smed-Sörensen, Johan K Sandberg.   

Abstract

Dendritic cells (DCs) play an important role in viral infections both as initiators of immunity and as viral targets. Interaction between DCs and the innate-like CD1d-restricted natural killer T (NKT) cells results in the mutual activation of both cells and the subsequent initiation of cellular immune responses. Here, we show that HIV-1 inhibits the surface expression of CD1d in productively infected DCs and identify this as a novel activity of the HIV-1 vpu gene product. Interestingly, the viral protein U (Vpu) does not enhance constitutive CD1d endocytosis or induce rapid CD1d degradation. Instead, the Vpu protein interacts with CD1d and suppresses its recycling from endosomal compartments to the cell surface by retaining CD1d in early endosomes. This interference with the CD1d antigen presentation pathway strongly inhibits the ability of infected DCs to activate CD1d-restricted NKT cells. Given that the interaction with CD1d-expressing DCs is central to the ability of NKT cells to regulate immunity, these data suggest that interference with the CD1d antigen presentation pathway represents an HIV-1 strategy to evade innate cellular immune responses and imply a role for the innate-like CD1d-restricted NKT cells in the host defense against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530791      PMCID: PMC3173986          DOI: 10.1182/blood-2009-09-243667

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.

Authors:  Ya-Hui Chiu; Se-Ho Park; Kamel Benlagha; Claire Forestier; Jayanthi Jayawardena-Wolf; Paul B Savage; Luc Teyton; Albert Bendelac
Journal:  Nat Immunol       Date:  2001-12-03       Impact factor: 25.606

2.  Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.

Authors:  A Karadimitris; S Gadola; M Altamirano; D Brown; A Woolfson; P Klenerman; J L Chen; Y Koezuka; I A Roberts; D A Price; G Dusheiko; C Milstein; A Fersht; L Luzzatto; V Cerundolo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.

Authors:  Edward B Stephens; Coleen McCormick; Erik Pacyniak; Darcy Griffin; David M Pinson; Francis Sun; Warren Nothnick; Scott W Wong; Robert Gunderson; Nancy E J Berman; Dinesh K Singh
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

4.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Authors:  Jochen Mattner; Kristin L Debord; Nahed Ismail; Randal D Goff; Carlos Cantu; Dapeng Zhou; Pierre Saint-Mezard; Vivien Wang; Ying Gao; Ning Yin; Kasper Hoebe; Olaf Schneewind; David Walker; Bruce Beutler; Luc Teyton; Paul B Savage; Albert Bendelac
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

5.  Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum.

Authors:  A Dharshan De Silva; J-June Park; Naoto Matsuki; Aleksandar K Stanic; Randy R Brutkiewicz; M Edward Medof; Sebastian Joyce
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

6.  NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.

Authors:  Teresa R Johnson; Seokmann Hong; Luc Van Kaer; Yasuhiko Koezuka; Barney S Graham
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer.

Authors:  Hiroto Kita; Olga V Naidenko; Mitchell Kronenberg; Aftab A Ansari; Paul Rogers; Xiao-Song He; Frits Koning; Toshifumi Mikayama; Judy Van De Water; Ross L Coppel; Marshall Kaplan; M Eric Gershwin
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection.

Authors:  Markus Moll; Carlotta Kuylenstierna; Veronica D Gonzalez; Sofia K Andersson; Lidija Bosnjak; Anders Sönnerborg; Máire F Quigley; Johan K Sandberg
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

10.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  70 in total

Review 1.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

2.  HIV-1 Vpu disarms natural killer cells.

Authors:  Jonathan Richard; Éric A Cohen
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

Authors:  Giulia Matusali; Marina Potestà; Angela Santoni; Cristina Cerboni; Margherita Doria
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

Authors:  Ankur H Shah; Bharatwaj Sowrirajan; Zachary B Davis; Jeffrey P Ward; Edward M Campbell; Vicente Planelles; Edward Barker
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

5.  HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4+ T Cells by NK Cells.

Authors:  Scott M Sugden; Tram N Q Pham; Éric A Cohen
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

6.  Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens.

Authors:  David Lau; Wilson Kwan; John Guatelli
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

7.  HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.

Authors:  Lara Manganaro; Elisa de Castro; Ana M Maestre; Kevin Olivieri; Adolfo García-Sastre; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

8.  Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors.

Authors:  Charlotte A Stoneham; Rajendra Singh; Xiaofei Jia; Yong Xiong; John Guatelli
Journal:  Traffic       Date:  2017-06-27       Impact factor: 6.215

Review 9.  Innate immunity in acute HIV-1 infection.

Authors:  Persephone Borrow
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

10.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.